The Piedmont-Aosta Valley Oncology Network experience in locally advanced HCC with intrahepatic neoplastic portal vein thrombosis: Y90-radioembolization versus Sorafenib. (February 2020) - Martelletti, C.; Gesualdo, M.; Carucci, P.; Gaia, S.; Burlone, M.; Okolicsanyi, S.; Grosso, M.; Pirisi, M.; Tabone, M.